Article Information
- Received May 31, 2002
- Revision received August 12, 2002
- Accepted August 23, 2002
- First published November 1, 2002.
- Version of record published November 1, 2002.
Author Information
Author contributions
Disclosures
- Received May 31, 2002.
- Revision received August 12, 2002.
- Accepted August 23, 2002.
This work was supported by fellowships from the Alberta Heritage Foundation for Medical Research and the Canadian Institutes of Health Research (A.J.F.) and by National Institutes of Health Grant R01 EY13475 and National Science Foundation Grant 1BN 9604843 (T.A.R.). We thank Josh Friedland-Little for providing expert technical assistance. We also thank Drs. D. Raible and R. Kubota for their comments that helped to contribute to the final form of this manuscript. The Pax6 and BrdU antibodies developed by Drs. A. Kawakami and S. J. Kaufman, respectively, were obtained from the Developmental Studies Hybridoma Bank developed under the auspices of the National Institute of Child Health and Human Development and maintained by the Department of Biological Sciences, University of Iowa (Iowa City, Iowa).
Correspondence should be addressed to Dr. Thomas A. Reh, Department of Biological Structure, University of Washington, Box 357420, Seattle, WA 98195. E-mail: tomreh{at}u.washington.edu.
Online Impact